Capital International Investors Catalent, Inc. Transaction History

Capital International Investors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$42.56 - $59.82 $65 Million - $91.3 Million	-1,526,537 Reduced 50.98%	1,467,930 $82.9 Million
Q4 2023 Feb 13, 2024	BUY	$32.18 - $46.57 $1.12 Million - $1.62 Million	34,856 Added 1.18%	2,994,467 $135 Million
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $23.4 Million - $26.6 Million	530,229 Added 21.83%	2,959,611 $135 Million
Q2 2023 Aug 11, 2023	BUY	$31.86 - $67.26 $32.6 Million - $68.9 Million	1,024,742 Added 72.95%	2,429,382 $105 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $63.8 Million - $104 Million	1,404,640 New	1,404,640 $92.3 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $56.3 Million - $65.5 Million	-471,016 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $47.8 Million - $59 Million	471,016 New	471,016 $49.6 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.